1. Home
  2. PHGE vs AWX Comparison

PHGE vs AWX Comparison

Compare PHGE & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • AWX
  • Stock Information
  • Founded
  • PHGE 2015
  • AWX 1998
  • Country
  • PHGE Israel
  • AWX United States
  • Employees
  • PHGE N/A
  • AWX N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • AWX Environmental Services
  • Sector
  • PHGE Health Care
  • AWX Utilities
  • Exchange
  • PHGE Nasdaq
  • AWX Nasdaq
  • Market Cap
  • PHGE 10.4M
  • AWX 9.7M
  • IPO Year
  • PHGE N/A
  • AWX 1998
  • Fundamental
  • Price
  • PHGE $0.52
  • AWX $2.46
  • Analyst Decision
  • PHGE Strong Buy
  • AWX
  • Analyst Count
  • PHGE 1
  • AWX 0
  • Target Price
  • PHGE $15.00
  • AWX N/A
  • AVG Volume (30 Days)
  • PHGE 991.6K
  • AWX 3.8K
  • Earning Date
  • PHGE 08-13-2025
  • AWX 08-08-2025
  • Dividend Yield
  • PHGE N/A
  • AWX N/A
  • EPS Growth
  • PHGE N/A
  • AWX 306.94
  • EPS
  • PHGE N/A
  • AWX 0.03
  • Revenue
  • PHGE N/A
  • AWX $78,200,000.00
  • Revenue This Year
  • PHGE N/A
  • AWX N/A
  • Revenue Next Year
  • PHGE N/A
  • AWX N/A
  • P/E Ratio
  • PHGE N/A
  • AWX $81.28
  • Revenue Growth
  • PHGE N/A
  • AWX N/A
  • 52 Week Low
  • PHGE $0.34
  • AWX $2.10
  • 52 Week High
  • PHGE $1.23
  • AWX $3.99
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 50.56
  • AWX 44.15
  • Support Level
  • PHGE $0.49
  • AWX $2.48
  • Resistance Level
  • PHGE $0.56
  • AWX $2.60
  • Average True Range (ATR)
  • PHGE 0.04
  • AWX 0.03
  • MACD
  • PHGE -0.01
  • AWX -0.00
  • Stochastic Oscillator
  • PHGE 49.28
  • AWX 22.22

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

Share on Social Networks: